Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study-Reference-Cited by-同舟云学术

Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study

Published:2018-06-27 Issue:12 Volume:20 Page:1936-1943
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Goette Andreas¹²,Kwong Winghan J³,Ezekowitz Michael D⁴,Banach Maciej⁵,Hjortshoj Soren P⁶,Zamoryakhin Dmitry⁷,Lip Gregory Y H⁸⁹

Affiliation:

1. St. Vincenz-Hospital Paderborn, Am Busdorf 2, Paderborn, Germany

2. Working Group: Molecular Electrophysiology, University Hospital Magdeburg, Magdeburg, Germany

3. Daiichi Sankyo, Inc., Basking Ridge, NJ, USA

4. Sidney Kimmel Jefferson Medical College at Thomas Jefferson University and Lankenau Medical Center, Broomall, PA, USA

5. Medical University of Lodz, Lodz, Poland

6. Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark

7. Daiichi Sankyo Development, Ltd, Gerrards Cross, UK

8. Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK

9. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Funder

Daiichi Sankyo, Inc

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/20/12/1936/26926874/euy141.pdf

Reference15 articles.

1. Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial;Goette;Lancet,2016

2. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial;Kirchhof;Lancet,2002

3. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society;January;Circulation,2014

4. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Europace,2016

5. Pharmacokinetics and pharmacodynamics of edoxaban, a non-vitamin K antagonist oral anticoagulant that inhibits clotting factor Xa;Parasrampuria;Clin Pharmacokinet,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Novel Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis;Cureus;2024-05-30

3. Safety and efficacy of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation electrical cardioversion: An update systematic review and meta-analysis;International Journal of Cardiology;2023-05

4. Manejo clínico da Fibrilação Atrial: uma revisão integrativa das evidências atuais;Journal of Education Science and Health;2022-04-15

5. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry;Clinical Research in Cardiology;2021-08-27